Specific bronchial sites of Mycobacterium kansasii in 2 patients with human immunodeficiency virus infection
Boudon, P.; Lepennec, M.P.; Malbec, D.; Mathieu, M.; Choudat, L.; Valeyre, D.
Annales de Medecine Interne 148(8): 577-578
1997
ISSN/ISBN: 0003-410X PMID: 9538404 Document Number: 479307
Document emailed within 1 workday
Related Documents
Boudon, P.; Lepennec, M.P.; Malbec, D.; Mathieu, M.; Choudat, L.; Valeyre, D. 1997: Localisations bronchiques spécifiques dues à Mycobacterium kansasii chez deux patients infectés par le virus de l'immuno-déficience humaine - Mycobactehum kansasii : a cause of treatable pulmonary disease associated with advanced human immuno-deficiency virus (HIV) infection Annales de Medecine Interne (Paris) 148(8): 577-578Martínez, T.; Creagh, R.; Saavedra, J.M.; Merino, D. 2000: Mycobacterium kansasii osteomyelitis in a patient infected by the human immunodeficiency virus Enfermedades Infecciosas y Microbiologia Clinica 18(3): 148-149
Kline, M.W.; Lewis, D.E.; Hollinger, F.B.; Reuben, J.M.; Hanson, L.C.; Kozinetz, C.A.; Dimitrov, D.H.; Rosenblatt, H.M.; Shearer, W.T. 1994: A comparative study of human immunodeficiency virus culture, polymerase chain reaction and anti-human immunodeficiency virus immunoglobulin A antibody detection in the diagnosis during early infancy of vertically acquired human immunodeficiency virus infection Pediatric Infectious Disease Journal 13(2): 90-94
Mancino, G.; Placido, R.; Bach, S.; Mariani, F.; Montesano, C.; Ercoli, L.; Zembala, M.; Colizzi, V. 1997: Infection of human monocytes with Mycobacterium tuberculosis enhances human immunodeficiency virus type 1 replication and transmission to T cells Journal of Infectious Diseases 175(6): 1531-1535
Kidangazhiayathmana, A. 2011: Is Kerala remaining low prevalent in human immunodeficiency virus by accident? a study of risk factors in acquiring human immunodeficiency virus infection in patients attending Anti-retroviral treatment clinic Indian Journal of Dermatology Venereology and Leprology 77(6): 729
Balzarini, J.; Velazquez, S.; San-Felix, A.; Karlsson, A.; Perez-Perez, M.J.; Camarasa, M.J.; De Clercq, E. 1993: Human immunodeficiency virus type 1-specific [2',5'-bis-O-(tert- butyldimethylsilyl)-beta-D-ribofuranosyl]-3'-spiro-5"-(4"-amino-1",2"- oxathiole-2",2"-dioxide)-purine analogues show a resistance spectrum that is different from that of the human immunodeficiency virus type 1-specific non-nucleoside analogues Molecular Pharmacology 43(1): 109-114
Sasaki, Y.; Yamagishi, F.; Suzuki, K.; Saitoh, M.; Izumizaki, M. 1997: A case of AIDS with disseminated Mycobacterium kansasii infection in which Mycobacterium, avium complex was also detected from his sputum repeatedly Kekkaku: 72(10): 573-577
Mosoko, J.J.; Macauley, I.B.; Zoungkanyi, A.-C.B.; Bella, A.; Koulla-Shiro, S. 2009: Human immunodeficiency virus infection and associated factors among specific population subgroups in Cameroon Aids and Behavior 13(2): 277-287
Gilad, J.; Walfisch, A.; Borer, A.; Schlaeffer, F. 2003: Gender differences and sex-specific manifestations associated with human immunodeficiency virus infection in women European Journal of Obstetrics Gynecology and Reproductive Biology 109(2): 199-205
Dumortier, J.ér.ôm.; Chiarello, P.; Adham, M.; Delafosse, B.; Chayvialle, J.-A.; Scoazec, J.-Y.; Boillot, O. 2002: Specific risks of liver transplantation in patients co-infected with hepatitis C virus and human immunodeficiency virus Gastroenterologie Clinique et Biologique 26(11): 1061-1062
Anonymous 1988: 1988 agent summary statement for human immunodeficiency virus and report on laboratory-acquired infection with human immunodeficiency virus Morbidity and Mortality Weekly Report 37(S-4): 22
Wen, Y.; Li, C.; Pei, J.; Bai, J.; Yang, X.; Duan, K. 2014: The incidence of oral candidiasis in patients with human immunodeficiency virus infection/acquired immunodeficiency syndrome from Yunnan, China Zhonghua Kou Qiang Yi Xue Za Zhi 49(8): 454-458
Lin, W.-C.; Lin, H.-H.; Lee, S.S.-J.; Sy, C.-L.; Wu, K.-S.; Chen, J.-K.; Tsai, H.-C.; Chen, Y.-S. 2016: Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country Journal of Microbiology Immunology and Infection 49(5): 729-736
Koyanagi, A.; Humphrey, J.H.; Ntozini, R.; Nathoo, K.; Moulton, L.H.; Iliff, P.; Mutasa, K.; Ruff, A.; Ward, B.; Chidawanyika, H.; Hargrove, J.; Mahomva, A.I.; Majo, F.; Malaba, L.C.; Mbizvo, M.T.; Mzengeza, F.; Ndhlovu, M.; Piwoz, E.; Propper, L.; Rambanepasi, P.; Ruff, A.J.; Tavengwa, N.; Zijenah, L.S.; Zunguza, C.D.; Zvandasara, P. 2011: Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy Pediatric Infectious Disease Journal 30(1): 45-51
Bélec, L.; Dupré, T.; Prazuck, T.; Tévi-Bénissan, C.; Kanga, J.M.; Pathey, O.; Lu, X.S.; Pillot, J. 1995: Cervicovaginal overproduction of specific IgG to human immunodeficiency virus (HIV) contrasts with normal or impaired IgA local response in HIV infection Journal of Infectious Diseases 172(3): 691-697
Diaz, A.; Ten, A.; Marcos, H.; Gutiérrez, G.; González-García, J.; Moreno, S.; Barrios, A.M.ía.; Arponen, S.; Portillo, Ál.; Serrano, R.; García, M.T.; Pérez, J.é L.; Toledo, J.; Royo, M.C.; González, G.; Izquierdo, A.; Viloria, L.J.; López, I.; Elizalde, L.áz.; Martínez, E.; Castrillejo, D.; Aranguren, R.; Redondo, C.; Diez, M. 2015: Factors determining irregular attendance to follow-up visits among human immunodeficiency virus patients: results of the hospital survey of patients infected with human immunodeficiency virus Enfermedades Infecciosas y Microbiologia Clinica 33(5): 324-330
Kaiser, T.; Tillmann, H.L. 2005: GB virus C infection: is there a clinical relevance for patients infected with the human immunodeficiency virus? Aids Reviews 7(1): 3-12
Kaiser, T.; Tillmann, H.L. 2005: GB virus C infection: is there a clinical relevance for patients infected with the human immunodeficiency virus? Aids Reviews 7(1): 3-12
Fagan, W.A.; Collins, P.C.; Pulitzer, D.R. 1996: Verrucous herpes virus infection in human immunodeficiency virus patients Archives of Pathology and Laboratory Medicine 120(10): 956-958
Balzarini, J.; Hatse, S.; Vermeire, K.; Princen, K.; Aquaro, S.; Perno, C-Federico.; De Clercq, E.; Egberink, H.; Vanden Mooter, G.; Peumans, W.; Van Damme, E.; Schols, D. 2004: Mannose-specific plant lectins from the Amaryllidaceae family qualify as efficient microbicides for prevention of human immunodeficiency virus infection Antimicrobial Agents and ChemoTherapy 48(10): 3858-3870